Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

HLA DRB1 alleles and hepatitis C virus infection in chronic kidney disease patients.

Shaheen NM, Soliman AR, El-Khashab SO, Hanna MO.

Ren Fail. 2013;35(3):386-90. doi: 10.3109/0886022X.2012.761038. Epub 2013 Feb 7.

PMID:
23391249
2.
3.

Association between human leukocyte antigen class I and II alleles and hepatitis C virus infection in high-risk hemodialysis patients awaiting kidney transplantation.

Grimaldi V, Sommese L, Picascia A, Casamassimi A, Cacciatore F, Renda A, De Rosa P, Montesano ML, Sabia C, Fiorito C, De Iorio G, Napoli C.

Hum Immunol. 2013 Dec;74(12):1629-32. doi: 10.1016/j.humimm.2013.08.008. Epub 2013 Aug 20.

PMID:
23974050
4.

HLA-DRB1 and susceptibility to kidney allograft rejection in Southern Iranian patients.

Gharesi-Fard B, Rezanezhad L, Karimi MH, Geramizadeh B, Salehipour MM, Hosseini SA, Roozbeh J.

Mol Biol Rep. 2014 Aug;41(8):5513-8. doi: 10.1007/s11033-014-3427-8. Epub 2014 Jun 6.

PMID:
24903971
5.

Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C.

Zavaglia C, Martinetti M, Silini E, Bottelli R, Daielli C, Asti M, Airoldi A, Salvaneschi L, Mondelli MU, Ideo G.

J Hepatol. 1998 Jan;28(1):1-7.

PMID:
9537846
6.

Hepatitis C virus-related hepatocellular carcinoma and B-cell lymphoma patients show a different profile of major histocompatibility complex class II alleles.

De Re V, Caggiari L, Talamini R, Crovatto M, De Vita S, Mazzaro C, Cannizzaro R, Dolcetti R, Boiocchi M.

Hum Immunol. 2004 Nov;65(11):1397-404.

PMID:
15556690
7.

Association study of human leukocyte antigen-DRB1 alleles with rheumatoid arthritis in south Tunisian patients.

Ben Hamad M, Mahfoudh N, Marzouk S, Kammoun A, Gaddour L, Hakim F, Fakhfakh F, Bahloul Z, Makni H, Maalej A.

Clin Rheumatol. 2012 Jun;31(6):937-42. doi: 10.1007/s10067-012-1954-z. Epub 2012 Feb 18.

PMID:
22349877
8.

Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus.

Kuzushita N, Hayashi N, Moribe T, Katayama K, Kanto T, Nakatani S, Kaneshige T, Tatsumi T, Ito A, Mochizuki K, Sasaki Y, Kasahara A, Hori M.

Hepatology. 1998 Jan;27(1):240-4.

PMID:
9425943
10.

Human leukocyte antigen class II alleles (DQB1 and DRB1) as predictors for response to interferon therapy in HCV genotype 4.

Shaker O, Bassiony H, El Raziky M, El-Kamary SS, Esmat G, El-Ghor AM, Mohamed MM.

Mediators Inflamm. 2013;2013:392746. doi: 10.1155/2013/392746. Epub 2013 Mar 14.

11.

Evidence for human leukocyte antigen heterozygote advantage against hepatitis C virus infection.

Hraber P, Kuiken C, Yusim K.

Hepatology. 2007 Dec;46(6):1713-21.

PMID:
17935228
12.

Associations of HLA-DRB1 alleles with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in northern east part of Turkey.

Uçar F, Çapkin E, Karkucak M, Yücel B, Sönmez M, Alver A, Kaklikkaya N, Tosun M, Alemdaroğlu E, Solak M.

Int J Rheum Dis. 2012 Dec;15(6):538-45. doi: 10.1111/j.1756-185X.2011.01604.x. Epub 2011 Mar 4.

PMID:
23253237
13.

Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia.

Cramp ME, Carucci P, Underhill J, Naoumov NV, Williams R, Donaldson PT.

J Hepatol. 1998 Aug;29(2):207-13.

PMID:
9722201
14.

Distribution of the human leukocyte antigen class II alleles in Brazilian patients with chronic hepatitis C virus infection.

Corghi DB, Gonçales NS, Marques SB, Gonçales Jr FL.

Braz J Med Biol Res. 2008 Oct;41(10):884-9. Epub 2008 Sep 30.

15.
16.

Influence of immunogenetic background on the outcome of recurrent hepatitis C after liver transplantation.

Belli LS, Zavaglia C, Alberti AB, Poli F, Rondinara G, Silini E, Taioli E, de Carlis L, Scalamogna M, Forti D, Pinzello G, Idèo G.

Hepatology. 2000 Jun;31(6):1345-50.

PMID:
10827162
17.

Ethnicity and route of HCV infection can influence the associations of HLA with viral clearance in an ethnically heterogeneous population.

de Almeida BS, Silva GM, da Silva PM, Perez Rde M, Figueiredo FA, Porto LC.

J Viral Hepat. 2011 Oct;18(10):692-9. doi: 10.1111/j.1365-2893.2010.01429.x. Epub 2011 Apr 8.

PMID:
21914086
18.

The association between the genetic polymorphism of HLA-DQA1, DQB1, and DRB1 and serum alanine aminotransferase levels in chronic hepatitis C in the Chinese population.

Yu RB, Hong X, Ding WL, Tan YF, Zhang YX, Sun NX, Wu GL, Zhan SW, Ge DF.

J Gastroenterol Hepatol. 2008 Sep;23(9):1394-402. Epub 2007 Nov 19.

PMID:
18028350
19.

Human leukocyte antigen DRB1 1302 protects against bile duct damage and portal lymphocyte infiltration in patients with chronic hepatitis C.

Haruna Y, Miyamoto T, Yasunami R, Kanda T, Fushimi H, Kotoh K.

J Hepatol. 2000 May;32(5):837-42.

PMID:
10845672
20.

Protective effect of HLA-DRB1 11 and predisposition of HLA-C 04 in the development of severe liver damage in Brazilian patients with chronic hepatitis C virus infection.

Marangon AV, Silva GF, de Moraes CF, Grotto RM, Pardini MI, de Pauli DS, Visentainer JE, Sell AM, Moliterno RA.

Scand J Immunol. 2012 Oct;76(4):440-7. doi: 10.1111/j.1365-3083.2012.02755.x.

Items per page

Supplemental Content

Write to the Help Desk